camizestrant,Fulvestrant
astrazeneca
['astrazeneca']
during the poster session at the 2023, showcased significant findings from the serena-2 phase ii trial. explore more: #cancerresearch #oncology #medicalconference #conference2023 #asco23 #ascoabstracts #ascoupdates #clinicaltrials 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry